Nimodipine in aneurysmal subarachnoid hemorrhage: A randomized study of intravenous or peroral administration - Clinical article

Journal of Neurosurgery

Volumn 110, Issue 1, 2009, Pages 58-63

  Kronvall, Erik ^a   Undrén, Per ^a   Romner, Bertil ^a   Säveland, Hans ^a   Cronqvist, Mats ^a   Nilsson, Ola G ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Aneurysm; Ischemia; Nimodipine; Subarachnoid hemorrhage; Vasospasm

Indexed keywords

NIMODIPINE; TRANEXAMIC ACID; CALCIUM CHANNEL BLOCKING AGENT;

ADULT; ARTICLE; BLEEDING; BLOOD FLOW VELOCITY; BRAIN INFARCTION; BRAIN RADIOGRAPHY; BRAIN VASOSPASM; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOPPLER ECHOGRAPHY; DRUG EFFICACY; FEMALE; GLASGOW OUTCOME SCALE; HEALTH STATUS; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MIDDLE CEREBRAL ARTERY; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT MONITORING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEX RATIO; SUBARACHNOID HEMORRHAGE; TREATMENT OUTCOME; AGED; BIOASSAY; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; ECHOGRAPHY; FOLLOW UP; GLASGOW COMA SCALE; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; ORAL DRUG ADMINISTRATION; PROSPECTIVE STUDY; RADIOGRAPHY;

ADMINISTRATION, ORAL; AGED; CALCIUM CHANNEL BLOCKERS; ENDPOINT DETERMINATION; FEMALE; FOLLOW-UP STUDIES; GLASGOW COMA SCALE; HUMANS; INJECTIONS, INTRAVENOUS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NIMODIPINE; PROSPECTIVE STUDIES; SUBARACHNOID HEMORRHAGE; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; VASOSPASM, INTRACRANIAL;

EID: 60749127288     PISSN: 00223085     EISSN: 19330693     Source Type: Journal    
DOI: 10.3171/2008.7.JNS08178     Document Type: Article

References (30)

1. Aaslid R, Huber P, Nornes H: Evaluation of cerebrovascular spasm with transcranial Doppler ultrasound. J Neurosurg 60: 37-41, 1984 (Pubitemid 14181553)
2. Barker FG II, Ogilvy CS: Efficacy of prophylactic nimodipine for delayed ischemic deficit after subarachnoid hemorrhage: a metaanalysis. J Neurosurg 84:405-414, 1996
3. Dorhout Mees SM, Rinkel G, Feigin V, Algra A, van den Bergh W, Vermeulen M, et al: Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev 3:CD000277, 2007
4. Dorsch NW: Therapeutic approaches to vasospasm in subarachnoid hemorrhage. Curr Opin Crit Care 8:128-133, 2002
5. Fisher CM, Kistler JP, Davis JM: Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery 6:1-9, 1980
6. Haley EC Jr, Kassell NF, Apperson-Hansen C, Maile MH, Alves WM: A randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in North America. J Neurosurg 86:467-474, 1997 (Pubitemid 27097093)
7. Haley EC Jr, Kassell NF, Torner JC: A randomised controlled trial of high-dose intravenous nicardipine in aneurysmal subarachnoid hemorrhage. A report of the cooperative aneurysm study. J Neurosurg 78:537-547, 1993
8. Hillman J, Fridriksson S, Nilsson O, Yu Z, Säveland H, Jakobsson KE: Immediate administration of tranexamic acid and reduced incidence of early rebleeding after aneurysmal subarachnoid hemorrhage: a prospective randomized study. J Neurosurg 97:771-778, 2002 (Pubitemid 35222396)
9. Hunt WE, Hess RM: Surgical risk as related to time of intervention in the repair of intracranial aneurysms. J Neurosurg 28:14-20, 1968
10. Jennett B, Bond M: Assessment of outcome after severe brain damage. Lancet 1:480-484, 1975
11. Karinen P, Koivukangas P, Ohinmaa A, Koivukangas J, Öh- man J: Cost-effectiveness analysis of nimodipine treatment after aneurysmal subarachnoid hemorrhage and surgery. Neurosurgery 45:780-784, 1999 (Pubitemid 29467805)
12. Kassell NF, Sasaki T, Colohan AR, Nazar G: Cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Stroke 16:562-572, 1985 (Pubitemid 15007226)
13. Kassell NF, Torner JC, Haley EC Jr, Jane JA, Adams HP, Kongable GL: The international cooperative study on the timing of aneurysm surgery. Part 1: Overall management results. J Neurosurg 73:18-36, 1990
14. Langley MS, Sorkin EM: Nimodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cerebrovascular disease. Drugs 37:669-699, 1989
15. Lysakowski C, Walder B, Costanza MC, Tramer MR: Transcranial Doppler versus angiography in patients with vasospasm due to a ruptured cerebral aneurysm: a systematic review. Stroke 32:2292-2298, 2001 (Pubitemid 32954797)
16. Macdonald RL: Management of cerebral vasospasm. Neurosurg Rev 29:179-193, 2006
17. Nilsson OG, Säveland H, Ramgren B, Cronqvist M, Brandt L: Impact of coil embolization on overall management and outcome of patients with aneurysmal subarachnoid hemorrhage. Neurosurgery 57:216-224, 2005 (Pubitemid 41098679)
18. Parra A, Kreiter KT, Williams S, Sciacca R, Mack WJ, Naidech AM, et al: Effect of prior statin use on functional outcome and delayed vasospasm after acute aneurysmal subarachnoid hemorrhage: a matched controlled cohort study. Neurosurgery 56:476-484, 2005 (Pubitemid 40316367)
19. Pickard JD, Murray GD, Illingworth R, Shaw MD, Teasdale GM, Foy PM, et al: Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial. BMJ 298:636-642, 1989 (Pubitemid 19088521)
20. Porchet F, Chiolero R, de Tribolet N: Hypotensive effect of ni modipine during treatment for aneurysmal subarachnoid haemorrhage. Acta Neurochir (Wien) 137:62-69, 1995
21. Säveland H, Hillman J, Brandt L, Edner G, Jakobsson KE, Algers G: Overall outcome in aneurysmal subarachnoid hemorrhage. A prospective study from neurosurgical units in Sweden during a 1-year period. J Neurosurg 76:729-734, 1992
22. Schmid-Elsaesser R, Kunz M, Zausinger S, Prueckner S, Briegel J, Steiger HJ: Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study. Neurosurgery 58:1054-1065, 2006 (Pubitemid 43879539)
23. Seiler RW, Grolimund P, Zurbruegg HR: Evaluation of the calcium- antagonist nimodipine for the prevention of vasospasm after aneurysmal subarachnoid haemorrhage. A prospective transcranial Doppler ultrasound study. Acta Neurochir (Wien) 85:7-16, 1987
24. Soppi V, Kokki H, Koivisto T, Lehtonen M, Helin-Tanninen M, Lehtola S, et al: Early-phase pharmacokinetics of enteral nimodipine in patients with acute subarachnoid haemorrhage - a pilot study. Eur J Clin Pharmacol 63:355-361, 2007 (Pubitemid 46399134)
25. Tseng MY, Czosnyka M, Richards H, Pickard JD, Kirkpatrick PJ: Effects of acute treatment with pravastatin on cerebral vasospasm, autoregulation, and delayed ischemic deficits after an eurysmal subarachnoid hemorrhage: a phase II randomized placebo-controlled trial. Stroke 36:1627-1632, 2005 (Pubitemid 41098752)
26. van den Bergh WM, Algra A, van Kooten F, Dirven CM, van Gijn J, Vermeulen M, et al: Magnesium sulfate in aneurysmal subarachnoid hemorrhage: a randomized controlled trial. Stroke 36:1011-1015, 2005
27. van Gijn J, Kerr RS, Rinkel GJ: Subarachnoid haemorrhage. Lancet 369:306-318, 2007 (Pubitemid 46136491)
28. Vinge E, Andersson KE, Brandt L, Ljunggren B, Nilsson LG, Rosendal-Helgesen S: Pharmacokinetics of nimodipine in patients with aneurysmal subarachnoid haemorrhage. Eur J Clin Pharmacol 30:421-425, 1986 (Pubitemid 16088200)
29. Vora YY, Suarez-Almazor M, Steinke DE, Martin ML, Findlay JM: Role of transcranial Doppler monitoring in the diagnosis of cerebral vasospasm after subarachnoid hemorrhage. Neurosurgery 44:1237-1247, 1999 (Pubitemid 29252743)
30. Zygmunt SC, Delgado-Zygmunt TJ: The haemodynamic effect of transcranial Doppler-guided high-dose nimodipine treatment in established vasospasm after subarachnoid haemorrhage. Acta Neurochir (Wien) 135:179-185, 1995